Aquestive Therapeutics(us:AQST)

    3.58

    -1.92%

    Updated on 2024-12-23

    Open:3.65
    Close:3.58
    High:3.66
    Low:3.52
    Pre Close:3.65
    Volume:523459.00
    Amount:1.87M
    Turnover:0.57%
    Shares:91.18M
    MarketCap:325.96M

    About Aquestive Therapeutics Company

    Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

    Company Name: Aquestive Therapeutics
    Company Address: 30 Technology Drive
    Employees: 135
    Fiscar Year: 12-31
    IPO Date: 2018-07-25
    CIK: 1398733

    View all SEC Filings

    About

    Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
    Address:30 Technology Drive
    Website:http://www.aquestive.com

    Market Movers